Cita APA (7a ed.)
Kitamura, H., Kobayashi, T., Kimura, G., Ikeda, M., Yonemori, K., Kawamura, N., . . . Kikuchi, E. (2/10/2025 Supplement5). Real-world effectiveness and treatment (tx) patterns in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in Japan: Results from the JAVEMACS chart review study. Journal of Clinical Oncology, 43, 701-943.
Cita Chicago Style (17a ed.)
Kitamura, Hiroshi, et al. "Real-world Effectiveness and Treatment (tx) Patterns in Patients (pts) with Locally Advanced/metastatic Urothelial Carcinoma (la/mUC) Receiving Avelumab First-line Maintenance (1LM) in Japan: Results from the JAVEMACS Chart Review Study." Journal of Clinical Oncology 43 (2/10/2025 Supplement5): 701-943.
Cita MLA (9a ed.)
Kitamura, Hiroshi, et al. "Real-world Effectiveness and Treatment (tx) Patterns in Patients (pts) with Locally Advanced/metastatic Urothelial Carcinoma (la/mUC) Receiving Avelumab First-line Maintenance (1LM) in Japan: Results from the JAVEMACS Chart Review Study." Journal of Clinical Oncology, vol. 43, 2/10/2025 Supplement5, pp. 701-943.
Precaución: Estas citas no son 100% exactas.